ClinicalTrials.govpublic full text
Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
ovarian cancer, peritoneal cancer, fallopian tube cancer, brca1 mutation, brca2 mutation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879117
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.